Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more

PrincipalinvestigatorStart date: 2012-12-24

NCT00429143Phase 1/2Completed

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

Hematologic Malignancies

Principalinvestigator

NCT01162096Phase 1/2Completed

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Hematological Malignancies

Principalinvestigator

NCT01341301Phase 2Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Hematologic Malignancy

Principalinvestigator

NCT01350245Phase 2Completed

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+7 more

Principalinvestigator

NCT01350258Phase 1/2Terminated

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Acute LeukemiaChronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI TherapyHematologic Malignancies+4 more

Principalinvestigator

NCT01532635Phase 2Terminated

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaALL+9 more

Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Hematologic Neoplasms5 Hodgkin Disease4 Leukemia, Lymphocytic, Chronic, B-Cell3 Lymphoma, Non-Hodgkin3 Precursor Cell Lymphoblastic Leukemia-Lymphoma2 Leukemia, Myeloid, Acute2 Anemia, Aplastic2 Lymphoma2

Affiliations

Thomas Jefferson University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dolores Grosso, DNP, CRNP

Thomas Jefferson University

Very Similar

7 trials

Shared therapeutic areas:

Hematologic NeoplasmsHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+17 more

Worked with same sponsors:

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborated on 4 trials

Similarity Score216%

Dolores Grosso, RN, CRNP, DNP

Thomas Jefferson University

Very Similar

1 trials

Shared therapeutic areas:

Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more

Worked with same sponsors:

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborated on 1 trial

Similarity Score214%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemiaLymphoma+10 more

Similarity Score11%

David Avigan, MD

Beth Israel Deaconess Medical Center

17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteAnemia, Aplastic+7 more

Similarity Score8%

Jorge Cortes, MD

M.D. Anderson Cancer Center

24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+6 more

Similarity Score8%

Qifa Liu

Nanfang Hospital, Southern Medical University

33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms+4 more

Similarity Score6%

Helen Heslop, MD

Baylor College of Medicine

17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+4 more

Similarity Score6%

Areej El-Jawahri, MD

Massachusetts General Hospital

21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsAML+3 more

Similarity Score5%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+3 more

Similarity Score5%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia+1 more

Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT01760655Phase 2PrincipalInvestigator

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more

Completed

NCT00429143Phase 1/2PrincipalInvestigator

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

Hematologic Malignancies

Completed

NCT01162096Phase 1/2PrincipalInvestigator

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Hematological Malignancies

Completed

NCT01341301Phase 2PrincipalInvestigator

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Hematologic Malignancy

Completed

NCT01350245Phase 2PrincipalInvestigator

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+7 more

Completed

NCT01350258Phase 1/2PrincipalInvestigator

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Acute LeukemiaChronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI TherapyHematologic Malignancies+4 more

Terminated

NCT01532635Phase 2PrincipalInvestigator

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaALL+9 more

Terminated

All 7 trials loaded